Key Data:
Drug (brand / generic)
Telbivudine
Company / licensee
Idenix Pharmaceuticals / Novartis Pharma
Therapy class
Nucleotide analogue
Product description
Oral L-deoxythymidine
Current indication
Chronic HBV infection
Market sector
Antiinfectives
Development status
Phase III